found that MiR-582-5p attenuates neonatal hypoxic-ischemic encephalopathy by targeting high mobility group box 1 (HMGB1) by inhibiting neuroinflammation and oxidative stress (118). This evidence concerns the gene HMGB1 and perinatal asphyxia.